-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Abivax, Lowers Price Target to $151

Benzinga·09/22/2026 13:19:14
Listen to the news
Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and lowers the price target from $155 to $151.